| CAS |
Product Name |
Molecular Formula |
Supplier |
|
5-Pyrimidinecarboxylic acid, 4-amino-2-methyl-, hydrazide |
C6H9N5O |
View |
|
4-AMINO-1-ETHYL-1 H-PYRAZOLE-3-CARBOXYLIC ACID (2-METHOXY-ETHYL)-AMIDE |
C9H16N4O2 |
View |
|
1H-Pyrazolo[4,3-d]pyriMidine, 5,7-dichloro-3-Methyl- |
C6H4Cl2N4 |
View |
|
1-((2,3-DIHYDROBENZOFURAN-5-YL)METHYL)PIPERIDINE-4-CARBOXYLIC ACID |
C15H19NO3 |
View |
|
4-(3,5-DIMETHYL-ISOXAZOL-4-YLMETHOXY)-3-METHOXY-BENZALDEHYDE |
C14H15NO4 |
View |
|
1-[3-(Difluoromethoxy)phenyl]-1H-pyrrole-2,5-dione |
C11H7F2NO3 |
View |
|
4-(N-THIOMORPHOLINYLSULFONYL)PHENYLBORONIC ACID |
C10H14BNO4S2 |
View |
|
2-(14,15-EPOXYEICOSATRIENOYL) GLYCEROL |
C23H38O5 |
View |
|
Isopropyl (Methyldiphenylsilyl)acetate |
C18H22O2Si |
View |
|
3-(4-chlorobenzyl)-11-(4-methoxyphenyl)-2-methyl-3H-pyrimido[5',4':4,5]pyrrolo[2,3-b]quinoxalin-4(11H)-one |
C27H20ClN5O2 |
View |
|
3-[3-(dimethylamino)propylamino]-7-methyl-1-pyrrolidin-1-yl-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile |
C19H30N6 |
View |
|
2-(4-Oxo-3-phenyl-4H-chroMen-8-yl)acetic acid |
C17H12O4 |
View |
|
N-benzyl-4-(4-methylpiperidin-1-yl)-3-nitrobenzamide |
C20H23N3O3 |
View |
|
PolyphyllinH |
C44H70O17 |
View |
|
Phosphonic acid, [2-[(3R,5S)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-2-methyl-3-isoxazolidinyl]ethyl]-, diethyl ester, rel- (9CI) |
C14H25N4O5P |
View |
|
2-(3',4'-DIHYDROXYBUTYL)QUINOXALINE |
C12H14N2O2 |
View |
|
D-glycero-D-talo-Non-2-enonic acid, 5-(acetylamino)-2,6-anhydro-3,5-dideoxy-, methyl ester, 7,8,9-triacetate |
C18H25NO11 |
View |
|
1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid, 4-[(2-methoxyethyl)amino]-3-methyl-1-(4-methylphenyl)-, ethyl ester |
C20H24N4O3 |
View |
|
1,3-Dioxolane, 2,2'-(bromomethylene)bis- |
C7H11BrO4 |
View |
|
7-CHLORO-2-(2,5-DICHLOROPHENYL)-8-METHYLQUINOLINE-4-CARBOXYLIC ACID |
C17H10Cl3NO2 |
View |
|
Antithrombin alfa |
|
View |
|
2-(5-Amino-2-chlorophenyl)acetonitrile |
C8H7ClN2 |
View |
|
Methyl 4-Bromo-5-azaindole-2-carboxylate |
C9H7BrN2O2 |
View |
|
2-PHENYLTHIOPHENE |
C10H8S |
View |
|
(R)-3,3'-Bis(3,5-di-tert-butylphenyl)-1,1'-binapthyl-2,2'-diyl hydrogenphosphate |
C48H53O4P |
View |
|
French verdigris |
|
View |
|
(2,6-DIETHYL-PHENYL)-HYDRAZINE |
C10H16N2 |
View |
|
N-(3,5-dimethoxyphenyl)-2-[(4-phenyl-5-pyridin-2-yl-1,2,4-triazol-3-yl)sulfanyl]acetamide |
C23H21N5O3S |
View |
|
Ospemifene Impurity 5 |
C22H19ClO |
View |
|
(3S,3'S,5S,5'S,6R,6'R)3,3'-[[(Phenylmethyl)imino]bis[(3S)-3-hydroxy-4,1-butanediyl]]bis[2-oxo-5,6-diphenyl-4-morpholinecarboxylic Acid Bis(tert-butyl) Ester |
C57H67N3O10 |
View |
|
Urea, N,N'-bis(phenylmethoxy)- |
C15H16N2O3 |
View |
|
2,5-Pyrrolidinedione, 1-(4-methyl-3-nitrophenyl)- |
C11H10N2O4 |
View |
|
1-PIPERIDIN-2-YLMETHYL-PIPERIDINE |
C11H22N2 |
View |
|
TIMTEC-BB SBB004161 |
C3H9ClN2O2 |
View |
|
Glycine, N-[(4-fluorophenyl)sulfonyl]glycyl- |
C10H11FN2O5S |
View |
|
citrusinine I |
C16H15NO5 |
View |
|
2-chloro-N-ethyl-N-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]benzamide |
C18H16ClN3O2 |
View |
|
2-[(4-methoxy-6-oxo-1,6-dihydropyrimidin-2-yl)sulfanyl]-N-(4-methylphenyl)propanamide |
C15H17N3O3S |
View |
|
Carbamic acid, N-[5-(2-aminoethyl)-2-thiazolyl]-, 1,1-dimethylethyl ester |
C10H17N3O2S |
View |
|
4-(4-aminophenoxy)butanoic acid |
C10H13NO3 |
View |
|
Phenophosphazine, 5,10-dihydro-5-methyl-10-phenyl- |
C19H16NP |
View |
|
(S)-N,N-Diethylpyrrolidin-3-aMine dihydrochloride |
C8H19ClN2 |
View |
|
5-[(2E)-2-[(3-methoxy-4-prop-2-enoxyphenyl)methylidene]hydrazinyl]-1,3-oxazole-4-carbonitrile |
C15H14N4O3 |
View |
|
4-(4-Trifluoromethylphenyl)-1,3,5-triazin-2-amine |
C10H7F3N4 |
View |
|
1-(4-BOC-AMINOBUTYL)PIPERAZINE |
C13H27N3O2 |
View |
|
Benzamide, 2-formyl- (9CI) |
C8H7NO2 |
View |
|
(6Z)-6-[[1-(2-chlorophenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-5-imino-2-phenyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one |
C24 H18 Cl N5 O S |
View |
|
3-(3-CHLORO-2-METHYLPHENYL)-2-THIOXO-2,3-DIHYDRO-4(1H)-QUINAZOLINONE |
C15H11ClN2OS |
View |
|
cis-(1,1-DiMethylethoxy)carbonyl TranexaMic Acid |
C13H23NO4 |
View |
|
Labetalol Hydrochloride Impurity 19((R,S)-Labetalol Hydrochloride) |
C19H25ClN2O3 |
View |